Trial Details

COMPLETED
Basic Information
Clinical ID c1614
Identifier NCT02209987
Trial Title Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: GS-5745 SC|DRUG: GS-5745 IV
Participant Information
Sponsor Gilead Sciences
City Christchurch
Country/Region New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-08-14
Primary Completion Date 2025-10-14
Completion Date 2025-10-14